NewsRx provides single-title site licenses to many of its subscription fee newsletters for corporate-wide use.
Each week enjoy unrestricted access to the latest medical research and drug development news, together with pertinent healthcare industry business and regulatory coverage. If you have multiple groups of employees who need access, this is the easiest way to share the subscription.
Login is via password and ID, or IP recognition, whichever is more convenient for you. NewsRx supports 24/7 access, which means you can view your newsletter any hour of the day, from any location -- a great convenience for your traveling employees.
NewsRx newsletters typically provide between 50 and 300 articles each week, covering every aspect of clinical research and drug development, including animal research, clinical trials, Food & Drug Administration actions, licensing and marketing agreements, patents, key personnel changes in pharmaceutical and biotech companies, as well as other business trends and news.
NewsRx editors collect their coverage from more than 4,000 peer-review journals, news wires, industry meetings, purchased databases, internet sites and press releases. Each article is a short, information-heavy read that quickly relays the pertinent facts, then provides full references and directions for accessing the original source material.
No other information source provides more information per publication and subject on a weekly basis than NewsRx. View sample issues of NewsRx newsletters.
A NewsRx single-title site license costs $5,190 per geographic location per year. Discounts are available for multiple sites or titles. To ask about discounts or any other questions, contact our publisher.
Each license allows unlimited access to the newsletter by an unlimited number of people from one geographical site. There's no better site license offer on the internet.
Here are the other NewsRx publications we offer as site licenses. If you wish to purchase now, click the Buy Now button at right and place your order.
Need to test our claims? We welcome you to sign up for a no-risk, six-week free trial. Just check off the newsletter you wish to view below and provide us with your email. If you want IP recognition, you'll need to provide us with a phone number so our technical folks can get you set up properly.
Our best read publications are:
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.